Back to Index
Laura A. Kalayjian, MD
Assistant Professor of Clinical Neurology
Neurology Chief, LAC+USC Medical Center
Director, Neurophysiology Lab, LAC+USC Medical Center
HCC 3rd Floor Room 3000 Health Sciences Campus Los Angeles
+1 323 442 5710


Dr. Laura Kalayjian is Chief of Neurology and Director of the EEG Lab at LAC+USC Medical Center. She completed medical school at the University of Massachusetts in Worcester, MA and completed her neurology residency at Stanford University, Palo Alto, CA. She was fellowship trained in epilepsy and neurophysiology under Dr. Martha Morrell at Columbia Presbyterian, New York. She accepted a position at USC in July 2000. She has been active as co-director of the comprehensive epilepsy program and continues to pursue her research interests in women with epilepsy, hormonal influences and pregnancy and quality of life issues in persons with epilepsy.


Pasadena Magazine : Top Doctor , 2011


A Single-Center Experience with the NeuroPace RNS System: A Review of Techniques and Potential Problems. World Neurosurg. 2015 Sep; 84(3):719-26. View in: PubMed

Valproate and pregnancy: Think again. Neurology. 2015 Jan 27; 84(4):e25-6. View in: PubMed

Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. JAMA Pediatr. 2014 Aug 1; 168(8):729-36. View in: PubMed

Predictive factors of neurological complications and one-month mortality after liver transplantation. Front Neurol. 2014; 5:275. View in: PubMed

Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years. Epilepsy Behav. 2013 Nov; 29(2):308-15. View in: PubMed

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol. 2013 Mar; 12(3):244-52. View in: PubMed

Differential effects of antiepileptic drugs on neonatal outcomes. Epilepsy Behav. 2012 Aug; 24(4):449-56. View in: PubMed

Progesterone vs placebo therapy for women with epilepsy: A randomized clinical trial. Neurology. 2012 Jun 12; 78(24):1959-66. View in: PubMed

Effects of fetal antiepileptic drug exposure: outcomes at age 4. 5 years. Neurology. 2012 Apr 17; 78(16):1207-14. View in: PubMed

Variation of seizure frequency with ovulatory status of menstrual cycles. Epilepsia. 2011 Oct; 52(10):1843-8. View in: PubMed

Fetal antiepileptic drug exposure: motor, adaptive, and emotional/behavioral functioning at age 3 years. Epilepsy Behav. 2011 Oct; 22(2):240-6. View in: PubMed

Premenstrual dysphoric disorder in women with epilepsy: relationships to potential epileptic, antiepileptic drug, and reproductive endocrine factors. Epilepsy Behav. 2011 Aug; 21(4):391-6. View in: PubMed

Relationship of child IQ to parental IQ and education in children with fetal antiepileptic drug exposure. Epilepsy Behav. 2011 Jun; 21(2):147-52. View in: PubMed

Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age. Brain. 2011 Feb; 134(Pt 2):396-404. View in: PubMed

Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology. 2010 Nov 30; 75(22):1954-60. View in: PubMed

Antiepileptic drug use in women of childbearing age. Epilepsy Behav. 2009 Jul; 15(3):339-43. View in: PubMed

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009 Apr 16; 360(16):1597-605. View in: PubMed

In utero antiepileptic drug exposure: fetal death and malformations. Neurology. 2006 Aug 8; 67(3):407-12. View in: PubMed

Sexual dysfunction, sex steroid hormone abnormalities, and depression in women with epilepsy treated with antiepileptic drugs. Epilepsy Behav. 2005 May; 6(3):360-5. View in: PubMed

Powered bySC CTSI